Number of metastatic organs negatively affects the treatment sequence in patients with EGFR ‐TKI failure

ConclusionA relatively large number of metastatic organs and a poor PS were associated with the withholding of subsequent chemotherapy after failure of EGFR ‐TKI inEGFR‐mutated NSCLC patients. Further research for patients with such a poor prognosis should be investigated in the future.

Source: Thoracic Cancer - February 21, 2020 Category: Cancer & Oncology Authors: Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe Tags: ORIGINAL ARTICLE Source Type: research